Alemtuzumab treatment for hemophagocytic lymphohistiocytosis
- PMID: 21080519
- DOI: 10.1038/nrclinonc.2010.40-c1
Alemtuzumab treatment for hemophagocytic lymphohistiocytosis
Comment on
-
Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.Nat Rev Clin Oncol. 2010 Jul;7(7):415-20. doi: 10.1038/nrclinonc.2010.40. Epub 2010 Apr 20. Nat Rev Clin Oncol. 2010. PMID: 20404855
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
